Survival curves comparing 4-year (A) EFS, (B) OS, and (C) RFS among pediatric AMKL patients with validated molecular aberrations in NUP98/KDMSA (blue), CBFA2T3/GLIS2 (red), rearrangements of KMT2 (light green), monosomy 7 (lime green), RBM15/MKL1 (light blue), and other (pink), identified as independent prognostic risk factors. See Figure 2D-F in the article by de Rooij et al that begins on page 3424.